RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.80
+0.03 (+3.33%)
Open$0.79
Previous Close$0.77
Day High$0.83
Day Low$0.78
52W High$3.87
52W Low$0.44
Volume—
Avg Volume720.5K
Market Cap108.00M
P/E Ratio—
EPS$-0.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+4,544.3% upside
Current
$0.80
$0.80
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.33M | 3.95M | 51.04M |
| Net Income | -60,580,238 | -64,630,410 | 8.38M |
| Profit Margin | -1,817.1% | -1,726.2% | 16.4% |
| EBITDA | -77,537,844 | -87,317,391 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | -15.6% | -15.6% | +13.5% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |